What You Need to Know About Surrozen
Headquartered in South San Francisco, Surrozen focuses on developing drugs by leveraging insights into the Wnt signaling pathway. Source: BioSpace
5 Biotechs Drawing Buyout Buzz in 2018
Here are five possible acquisition targets to keep an eye on. Source: BioSpace
Novartis Poised for Growth as CEO Hands Baton to Successor
Narasimhan takes over the role of CEO in February as current CEO Joe Jimenez retires. Source: BioSpace
Why This Heart Drug Could Be a $5B Blockbuster for Novartis
Entresto, introduced in 2015, got off to a slow start but brought in $507 million in revenue last year. Source: BioSpace
AI Biotech Startup XtalPi Scores $15M From Google, Tencent and Sequoia
The latest funding round gives XtalPi $20M in the bank, which the company said makes it "one of the top-funded AI-powered biotechs." Source: BioSpace
Denali Top Exec Jumps Ship for Bay Area Anti-Aging Startup Alkahest
Hannestad will be responsible for Alkahest's clinical programs in Alzheimer's and Parkinson's Disease. Source: BioSpace
New Kid Tmunity Banks $100M From Gilead and Facebook Billionaire Sean Parker
The funds raised will partly go towards funding two clinical trials that have already opened. Source: BioSpace
Bay Area's GigaGen Moves to New Space to Accommodate Growth
GigaGen completed relocation to One Tower Place in late December 2017. Source: BioSpace
3 Biotechs That Have Doubled Investors' Money in Less Than a Year
Having a stock double in value is a good thing. Source: BioSpace
Gilead's Kite Pays $135M for Ex-Agensys R&D Building
The latest acquisition makes it the highest amount paid for a flex R&D building in Los Angeles County. Source: BioSpace
- Go to the previous page
- 1
- …
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- …
- 288
- Go to the next page